retatrutide efficacy clinical trials (RETA) is one of the most promising investigational peptides in obesity research—but one important question deserves more attention: Can it affect birth control? Current evidence shows that GLP-1 Perceived benefits of treatment for

Some products have been found to contain incorrect amounts of peptide, contaminants, or different compounds entirely

In the paper, Banks called it troubling how easy it is to obtain a prescription for weight loss drugs and worried they might exacerbate existing eating disorders or cause new cases, including of anorexia

This reflects the rapidly rising demand and expanding use of GLP-1 therapies across the globe

Cardiovascular outcome studies will provide data essential for regulatory approval and insurance coverage decisions

The supply chain is straining under demand, and where there are cracks, opportunists rush in